mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.6 |
mRNA |
CAY10576 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.7 |
mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.7 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |